化疗联合康艾注射液在晚期结直肠癌中的疗效观察

目的研究分析化疗联合康艾注射液在晚期结直肠癌中的临床疗效。方法收治100例晚期结直肠癌患者,随机分为对照组和观察组各50例。对照组患者进行单纯的化疗治疗,观察组患者在化疗的同时进行康艾注射液治疗,两周后,对患者的临床疗效进行评价。结果对照组患者的临床总有效率为30%,观察组为46%,两组差异有统计学意义(P<0.05)。对照组患者的包细胞下降程度和肝功能异常的发生率明显高于观察组(P<0.05)。观察组患者的体力状况改善情况好于对照组(P<0.05)。结论晚期结直肠癌患者进行化疗联合康艾注射液治疗,不仅仅有着较好的近期疗效,同时也能将化疗的毒副作用减轻,对患者的临床症状有效改善,将患者的生存质量显著提高。

Objectfve To study the clinical efficacy of chemotherapy combined with Kangai injection in advanced colorectal cancer.Methods 100 patients with advanced colorectal cancer were randomly divided into control group and observation group.30 cases in each group.The control group were treated with simple chemotherapy in the treatment of,the observation group patients in chemotherapy of Kangai injection in the treatment,two weeks later,the clinical curative effect of patients was evaluated.Results the clinical total effective rate was 30%in the control group,the clinical total effective rate was 46%in the observation group,the clinical total effective rate was higher in the observation group,and the P<0.05 was statistically significant.In control group,the incidence of P<0.05 and the abnormal liver function were significantly higher than those in the observation group,and the control group was statistically significant.The improvement of the physical condition of the patients in the observation group was better than that in the control group.P<0.05.and it was statistically significant.Conclusion advanced colon rectal cancer patients with chemotherapy combined with Kangai injection in the treatment of.not only has good short- term effect,also can reduce the side effects of chemotherapy,improve the patient's clinical symptoms,quality of life of the patients improved significantly.